Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Many Canadian cities are experiencing ongoing infectious disease and overdose epidemics among injection drug users (IDUs). In particular, Human Immunodeficiency Virus (HIV) and hepatitis C Virus (HCV) have become endemic in many settings and bacterial and viral infections, such as endocarditis and cellulitis, have become extremely common among this population. In an effort to reduce these public health concerns and the public order problems associated with public injection drug use, in September 2003, Vancouver, Canada opened a pilot medically supervised safer injecting facility (SIF), where IDUs can inject pre-obtained illicit drugs under the supervision of medical staff. The SIF was granted a legal exemption to operate on the condition that its impacts be rigorously evaluated. In order to ensure that the evaluation is appropriately open to scrutiny among the public health community, the present article was prepared to outline the methodology for evaluating the SIF and report on some preliminary observations. The evaluation is primarily structured around a prospective cohort of SIF users, that will examine risk behavior, blood-borne infection transmission, overdose, and health service use. These analyses will be augmented with process data from within the SIF, as well as survey's of local residents and qualitative interviews with users, staff, and key stakeholders, and standardised evaluations of public order changes. Preliminary observations suggest that the site has been successful in attracting IDUs into its programs and in turn helped to reduce public drug use. However, each of the indicators described above is the subject of a rigorous scientific evaluation that is attempting to quantify the overall impacts of the site and identify both benefits and potentially harmful consequences and it will take several years before the SIF's impacts can be appropriately examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the cohort was assembled through random recruitment of IDUs from within the SIF [15].”
From Community-associated methicillin-resistant Staphylococcus aureus is prevalent in wounds of community-based injection drug users (2010) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Des Jarlais, D. C., Lyles, C., Crepaz, N., & the TREND Group (2004) · American Journal of Public Health · doi:10.2105/ajph.94.3.361 · Cited by 2,817 · cited 1×
“Since several years were devoted to the development of the Vancouver SIF evaluation methodology, and since the investigators wished to be as open with methodology as possible [21], the present article was prepared to describe the framework of the evaluation and to report on preliminary observations.”
MethodNeedle exchange is not enough: lessons from the Vancouver injecting drug use study
Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M. L., Montaner, J. S. G., Schechter, M. T., & OʼShaughnessy, M. V. (1997) · AIDS · doi:10.1097/00002030-199708000-00001 · Cited by 661
Self-citationStrathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., & Nelson, K. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.10.1281 · Cited by 331
Wood, E. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040774 · Cited by 267 · cited 2×
“An evaluation of these indicators has recently been described in detail [26].”
BackgroundSelf-citationHospital utilization and costs in a cohort of injection drug users.
(2001) · PubMed Central · Cited by 263
Self-citationRisk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
Craib, K. J. P., Spittal, P. M., Wood, E., Laliberté, N., Hogg, R. S., Li, K. K., Heath, K., TYNDALL, M. W., O’Shaughnessy, M. V., & Schechter, M. T. (2003) · PubMed · Cited by 211
Self-citationDolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D., & Trautmann, F. (2000) · Drug and Alcohol Review · doi:10.1080/713659379 · Cited by 174 · cited 2×
“SIF typically have several primary objectives including: the reduction of public drug use, fatal and non-fatal overdose, and infectious disease risk; improving contact between a highly marginalized 'at-risk' population and the healthcare system; and enhancing recruitment into medical care and addiction treatment [9-11…”
BackgroundSchechter, M. T., Strathdee, S. A., Cornelisse, P. G. A., Currie, S., Patrick, D. M., Rekart, M. L., & O‚Shaughnessy, M. V. (1999) · AIDS · doi:10.1097/00002030-199904160-00002 · Cited by 172
Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives
Broadhead, R. S., Kerr, T. H., Grund, J.-P. C., & Altice, F. L. (2002) · Journal of Drug Issues · doi:10.1177/002204260203200113 · Cited by 153 · cited 2×
“SIF typically have several primary objectives including: the reduction of public drug use, fatal and non-fatal overdose, and infectious disease risk; improving contact between a highly marginalized 'at-risk' population and the healthcare system; and enhancing recruitment into medical care and addiction treatment [9-11…”
BackgroundSelf-citationLeaving hospital against medical advice among HIV-positive patients.
Anis, A. H., Sun, H., Guh, D. P., Palepu, A., Schechter, M. T., & O’Shaughnessy, M. V. (2002) · Europe PMC (PubMed Central) · Cited by 141
Research works printed but not linked: 2
- Kemmesies U: Final Report: The open drug scene and the safe injection room offers in Frankfurt am Main. 1999
- Van Beek I, Dakin A, Kimber J: Drug overdoses in a supervised injecting room setting. 14th Int Conf on Reduction of Drug Related Harm. Chiang Mai, Thailand; April 6-10, 2003.
Cited by
Marshall, B. D., Milloy, M.-J., Wood, E., Montaner, J. S., & Kerr, T. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62353-7 · Cited by 479
Self-citationMcNeil, R., Small, W., Wood, E., & Kerr, T. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.01.010 · Cited by 284
Self-citationPredictors of non-fatal overdose among a cohort of polysubstance-using injection drug users
Kerr, T., Fairbairn, N., Tyndall, M., Marsh, D., Li, K., Montaner, J., & Wood, E. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.07.009 · Cited by 313
Self-citationPublic injection settings in Vancouver: Physical environment, social context and risk
Small, W., Rhodes, T., Wood, E., & Kerr, T. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.019 · Cited by 214
Self-citationSummary of findings from the evaluation of a pilot medically supervised safer injecting facility
Wood, E., Tyndall, M. W., Montaner, J. S., & Kerr, T. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060863 · Cited by 187
Self-citation
Metadata
- Authors
- Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W.
- Affiliations
- St. Paul's Hospital (CA)
- Vancouver Coastal Health (CA)
- University of British Columbia (CA)
- Corresponding author
- Wood, Evan
- Venue
- Harm Reduction Journal
- Published
- 2004-11-09
- Volume
- 1
- Issue
- 1
- Pages
- 9-9
- ISSN
- 1477-7517 (ISSN-L)
- PMC
- PMC535533
- OpenAlex
- W1882180401
- Cited by
- 107
- References
- 22
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 4 · 2019: 5 · 2018: 2 · 2017: 6 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 7
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Harm Reduction Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Open Collections
- Funders
- Health Canada
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Sociology and Political Science › Homelessness and Social Issues
- Keywords
- people who inject drugs, harm reduction, Insite, Vancouver, HIV transmission, hepatitis C, drug overdose, bloodborne infections, public order, risk-taking, health care utilization, program evaluation methodology, pilot project
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. https://app.cochat.ai/papers/10.1186/1477-7517-1-9
- The paper
- Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004). Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal. https://doi.org/10.1186/1477-7517-1-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.